Activation of Free Fatty Acid Receptor 4 (FFA4) Ameliorates Ovalbumin-Induced Allergic Asthma by Suppressing Activation of Dendritic and Mast Cells in Mice

被引:17
|
作者
Son, So-Eun [1 ]
Koh, Jung-Min [2 ]
Im, Dong-Soon [1 ,3 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Biomed & Pharmaceut Sci, Seoul 02447, South Korea
[2] Univ Ulsan, Div Endocrinol & Metab, Asan Med Ctr, Coll Med, Seoul 05505, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Basic Pharmaceut Sci, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
allergy; asthma; free fatty acid receptor 4; FFA4; omega-3 polyunsaturated fatty acids; DAMPENS AIRWAY INFLAMMATION; DIETARY SUPPLEMENTATION; INSULIN-RESISTANCE; RESOLVIN E1; GPR120; OMEGA-3-FATTY-ACIDS; RESOLUTION; LIPIDS; MODEL;
D O I
10.3390/ijms23095270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidemiological and clinical studies have suggested that intake of n-3 polyunsaturated fatty acids (PUFA) reduces the incidence of allergic airway diseases and improves pulmonary function in patients with allergic asthma. However, the pharmacological targets of PUFA have not been elucidated upon. We investigated whether free fatty acid receptor 4 (FFA4, also known as GPR120) is a molecular target for beneficial PUFA in asthma therapy. In an ovalbumin (OVA)-induced allergic asthma model, compound A (a selective agonist of FFA4) was administrated before OVA sensitization or OVA challenge in FFA4 wild-type (WT) and knock-out (KO) mice. Compound A treatment of RBL-2H3 cells suppressed mast cell degranulation in vitro in a concentration-dependent manner. Administration of compound A suppressed in vivo allergic characteristics in bronchoalveolar lavage fluid (BALF) and lungs, such as inflammatory cytokine levels and eosinophil accumulation in BALF, inflammation and mucin secretion in the lungs. Compound A-induced suppression was not only observed in mice treated with compound A before OVA challenge, but in mice treated before OVA sensitization as well, implying that compound A acts on mast cells as well as dendritic cells. Furthermore, this suppression by compound A was only observed in FFA4-WT mice and was absent in FFA4-KO mice, implying that compound A action is mediated through FFA4. Activation of FFA4 may be a therapeutic target of PUFA in allergic asthma by suppressing the activation of dendritic cells and mast cells, suggesting that highly potent specific agonists of FFA4 could be a novel therapy for allergic asthma.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Free Fatty Acid Receptor 4 (FFA4) Activation Ameliorates Imiquimod-Induced Psoriasis in Mice
    Son, So-Eun
    Koh, Jung-Min
    Im, Dong-Soon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [2] 4-CMTB Ameliorates Ovalbumin-Induced Allergic Asthma through FFA2 Activation in Mice
    Lee, Ju-Hyun
    Im, Dong-Soon
    BIOMOLECULES & THERAPEUTICS, 2021, 29 (04) : 427 - 433
  • [3] Free fatty acid receptor 4 (FFA4) activation attenuates obese asthma by suppressing adiposity and resolving metaflammation
    Son, So-Eun
    Koh, Jung-Min
    Im, Dong-Soon
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [4] Dihydromyricetin inhibited ovalbumin-induced mice allergic responses by suppressing the activation of mast cells
    Zhang, Ya-Fen
    Liu, Qing-Mei
    Liu, Bo
    Shu, Zhen-Dan
    Han, Jing
    Liu, Hong
    Cao, Min-Jie
    Yang, Xian-Wen
    Gu, Wei
    Liu, Guang-Ming
    FOOD & FUNCTION, 2019, 10 (11) : 7131 - 7141
  • [5] Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice
    Son, So-Eun
    Park, Soo-Jin
    Koh, Jung-Min
    Im, Dong-Soon
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (10) : 1337 - 1347
  • [6] Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice
    So-Eun Son
    Soo-Jin Park
    Jung-Min Koh
    Dong-Soon Im
    Acta Pharmacologica Sinica, 2020, 41 : 1337 - 1347
  • [7] Sophoricoside from Sophora japonica ameliorates allergic asthma by preventing mast cell activation and CD4+ T cell differentiation in ovalbumin-induced mice
    Kim, Byung-Hak
    Lee, Sanghyun
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [8] Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist
    Sparks, Steven M.
    Aquino, Christopher
    Banker, Pierette
    Collins, Jon L.
    Cowan, David
    Diaz, Caroline
    Dock, Steven T.
    Hertzog, Donald L.
    Liang, Xi
    Swiger, Erin D.
    Yuen, Josephine
    Chen, Grace
    Jayawickreme, Channa
    Moncol, David
    Nystrom, Christopher
    Rash, Vincent
    Rimele, Thomas
    Roller, Shane
    Ross, Sean
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (05) : 1278 - 1283
  • [9] Pathophysiological regulation of lung function by the free fatty acid receptor FFA4
    Prihandoko, Rudi
    Kaur, Davinder
    Wiegman, Coen H.
    Alvarez-Curto, Elisa
    Donovan, Chantal
    Chachi, Latifa
    Ulven, Trond
    Tyas, Martha R.
    Euston, Eloise
    Dong, Zhaoyang
    Alharbi, Abdulrahman Ghali M.
    Kim, Richard Y.
    Lowe, Jack G.
    Hansbro, Philip M.
    Chung, Kian Fan
    Brightling, Christopher E.
    Milligan, Graeme
    Tobin, Andrew B.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (557)
  • [10] Regulation of cell survival through free fatty acid receptor 1 (FFA1) and FFA4 induced by endothelial cells in osteosarcoma cells
    Minami, Kanako
    Ueda, Nanami
    Ishimoto, Kaichi
    Tsujiuchi, Toshifumi
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2020, 40 (02) : 181 - 186